Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> SANOFI Latest News

JAN 13, 2015 - Yahoo! News

A Must Read - Share

U.S. insurers squeeze diabetes drug prices : Eli Lilly

By Caroline Humer and Deena Beasley SAN FRANCISCO (Reuters) - Eli Lilly and Co said on Monday that U.S. insurers are increasing pressure on the price of diabetes medications as they switch coverage from certain drugs to others to trim costs. At the same time, Lilly's financial chief believes its products produce better results for patients and will help the ...

Tags: U.S. insurers squeeze diabetes drug prices : Eli Lilly,  Sanofi Latest News

JAN 12, 2015 - Yahoo! News

A Must Read - Share

Sanofi, Regeneron submit new cholesterol drug to EMA for review

PARIS (Reuters) - The European Medicines Agency has agreed to review an application by Sanofi and Regeneron for their cholesterol-lowering drug alirocumab, the pharmaceutical groups said in a statement. The drug, for which the companies have proposed the market name Praluent, has also been under review by the U.S. Food and Drug Administration since the fourth quarter of 2014. (Reporting ...

Tags: Sanofi, Regeneron submit new cholesterol drug to EMA for review,  Sanofi Latest News

JAN 09, 2015 - Yahoo! News

A Must Read - Share

Sanofi, Regeneron cholesterol drug also effective in monthly doses

(Reuters) - An experimental drug from Sanofi SA and Regeneron Pharmaceuticals was found to be effective in lowering "bad" cholesterol even when administered once every four weeks, instead of every two weeks. The drug, alirocumab, belongs to an emerging class of injectable drugs that block a naturally occurring protein called PCSK9, which inhibits the liver from expelling "bad" LDL cholesterol. ...

Tags: Sanofi, Regeneron cholesterol drug also effective in monthly doses,  Sanofi Latest News

JAN 09, 2015 - Yahoo! News

A Must Read - Share

Sanofi, Regeneron announce positive trials of cholesterol drug

PARIS (Reuters) - Pharmaceutical groups Sanofi and Regeneron announced on Friday that two clinical trials showed that a monthly dose of experimental drug alirocumab was effective in patients with high cholesterol. In both trials, the drug administered every four weeks "met their primary efficacy endpoints", the companies said. "In the new monthly dosing trials...the mean percent reduction in LDL-C from ...

Tags: Sanofi, Regeneron announce positive trials of cholesterol drug,  Sanofi Latest News